A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Nitrazepam
Abediterol
The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Abediterol.
Nitrazepam
PF-00610355
The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with PF-00610355.
Nitrazepam
Etafedrine
The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Etafedrine.
Nitrazepam
Racepinephrine
The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Racepinephrine.
Nitrazepam
Doxofylline
The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Doxofylline.
Nitrazepam
Vilanterol
The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Vilanterol.
Nitrazepam
Olodaterol
The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Olodaterol.
Nitrazepam
Hexoprenaline
The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Hexoprenaline.
Nitrazepam
Protokylol
The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Protokylol.
Nitrazepam
Celiprolol
The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Celiprolol.
Nitrazepam
Deferasirox
The risk or severity of gastrointestinal ulceration and gastrointestinal irritation can be increased when Hydrocortisone cypionate is combined with Deferasirox.
Nitrazepam
Corticorelin ovine triflutate
The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Hydrocortisone cypionate.
Cinolazepam
Satralizumab
The serum concentration of Hydrocortisone butyrate can be decreased when it is combined with Satralizumab.
Cinolazepam
Oliceridine
The serum concentration of Oliceridine can be decreased when it is combined with Hydrocortisone butyrate.
Cinolazepam
Abametapir
The serum concentration of Hydrocortisone butyrate can be increased when it is combined with Abametapir.
Cinolazepam
Inebilizumab
The risk or severity of infection can be increased when Hydrocortisone butyrate is combined with Inebilizumab.
Cinolazepam
Selpercatinib
The serum concentration of Selpercatinib can be decreased when it is combined with Hydrocortisone butyrate.
Cinolazepam
Cyclopenthiazide
The risk or severity of electrolyte imbalance can be increased when Hydrocortisone butyrate is combined with Cyclopenthiazide.
Cinolazepam
Mebutizide
The risk or severity of electrolyte imbalance can be increased when Hydrocortisone butyrate is combined with Mebutizide.
Cinolazepam
Lumateperone
The serum concentration of Lumateperone can be decreased when it is combined with Hydrocortisone butyrate.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3